Open AccessSystemic bone‐seeking radionuclides for palliation of painful osseous metastases: Current concepts
Author(s) -
Mertens Wilson C.,
Filipczak Linda A.,
BenJosef Edgar,
Davis Lawrence P.,
Porter Arthur T.
Publication year - 1998
Publication title -
ca: a cancer journal for clinicians
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 62.937
H-Index - 168
eISSN - 1542-4863
pISSN - 0007-9235
DOI - 10.3322/canjclin.48.6.361
Subject(s) - medicine , radionuclide therapy , treatment modality , palliative care , quality of life (healthcare) , palliative treatment , bone metastasis , analgesic , bone pain , metastasis , surgery , nuclear medicine , cancer , anesthesia , nursing
Bone metastases require multidisciplinary treatment, the primary goal of which is to relieve pain and improve quality of life. Among the options available, bone-seeking radioisotopes are attractive because they can treat several symptomatic metastases simultaneously. This therapy may have antitumor efficacy in addition to analgesic properties. Although the ultimate place of systemic radionuclides in the treatment of bone metastases has not been firmly established, some patients clearly benefit from these modalities.